GLAM
TNDM icon

Gardner Lewis Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Gardner Lewis Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-21,385
Closed -$812K – 79
2018
Q4 		$812K Buy
+21,385
New +$755K 0.07% 64

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Gardner Lewis Asset Management's TNDM Position: Q1 2019 in Review

Gardner Lewis Asset Management sold out of Tandem Diabetes Care (TNDM) in Q1 2019, closing a stake of 21,385 shares — an estimated $812K sold.

Gardner Lewis Asset Management first reported a position in TNDM in Q4 2018 and held it in 1 quarter. The position peaked at $812K in Q4 2018. 265 funds tracked by Wall St. Rank hold TNDM as of Q1 2019.

  • Gardner Lewis Asset Management reported no remaining Tandem Diabetes Care position as of Q1 2019 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 21,385 Tandem Diabetes Care shares in Q1 2019, an estimated $812K.
  • Gardner Lewis Asset Management first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 1 quarter.
  • Gardner Lewis Asset Management's Tandem Diabetes Care position peaked at $812K in Q4 2018.
  • 265 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2019.

Based on Gardner Lewis Asset Management's 13F filing for Q1 2019, filed 15 May 2019.